Please Wait...

Patient Recruitment and Retention for Healthier Studies

Elizabeth Thiele

Finding patients to participate in clinical trials and keeping them engaged for the duration are two of the greatest challenges in the clinical development process. Yet, as our President and CEO John Hubbard sees it, "Every major challenge is also an opportunity to improve the clinical development process." To overcome such hurdles, we as an industry must become more efficient in conducting clinical trials while simultaneously keeping a keen focus on the patient. Opportunities abound for more effective and efficient methods to accomplish patient identification, screening, enrollment and retention.

Finding and enrolling the right patients for the right clinical trials is part of a healthy, patient-centric approach taken by Bioclinica's Patient Recruitment and Retention division. The team has a 94 percent overall success rate, with more than 200 programs successfully completed in a variety of therapeutic areas.

The approach is outlined by Elizabeth Thiele, President of our Global Clinical Research business segment, in an episode of Worldwide Business with Kathy Ireland that aired earlier this year. Elizabeth discusses the difficulty in finding eligible patients, particularly when it comes to research in areas like Alzheimer's. Tune in to the program excerpt below to hear Elizabeth explain our multi-pronged approach.

Bioclinica's Patient Recruitment and Retention Division spotlighted on Worldwide Business with Kathy Ireland!

This sponsored programming originally aired on Worldwide Business with Kathy Ireland on the Fox Business Network on April 3, 2016.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Bioclinica’s Joby John reflects on the #SCDM2018 Annual Conference & being a part a thriving community of clinical… https://t.co/c70gH5kJo9
bioclinica (11 hours ago)
RT @bioclinica: Our own Jeff Heilbraun is in Tokyo nxt wk to lead a discussion at DIA’s Cardiac Safety Workshop in Japan. Jeff will give an…
bioclinica (16 hours ago)
RT @Xtalks: Trends in #SitePayments: Insight into How CROs Can Gain a Competitive Edge This webinar will focus on the latest market researc…
bioclinica (16 hours ago)
Great connecting w @bioclinica clients Odonate Therapeutics, Eisai, & PCI Biotech, at #ESMO18 #oncology… https://t.co/4wKrLof8e6
bioclinica (18 hours ago)
Our own Jeff Heilbraun is in Tokyo nxt wk to lead a discussion at DIA’s Cardiac Safety Workshop in Japan. Jeff will… https://t.co/BX6wzXctMm
bioclinica (3 days ago)
Let's talk oncology clinical trials at #ESMO18 ! Tap the knowledge of medical & scientific experts @bioclinica who'… https://t.co/RlTjGND5Qg
bioclinica (4 days ago)

Latest Blogs:

Dr. Joby John
Transformational Trends in Investigator Site Payments
Clinical Supply Chain Success: Leveraging Technology
Blood pressure monitor
Prescription box
Latin America: Benefit from the Right Partner